Clinical trial
Study of Bexarotene in Patients With Acute Myeloid Leukemia
NCT00316030 · Abramson Cancer Center at Penn Medicine, Other · Completed
Key facts
| NCT number | NCT00316030 |
|---|---|
| Title | Study of Bexarotene in Patients With Acute Myeloid Leukemia |
| Official title | A Phase I Study of Bexarotene in Patients With Acute Myeloid Leukemia |
| Lead sponsor | Abramson Cancer Center at Penn Medicine, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | AML, Acute Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | Bexarotene |
| Enrollment | 54 |
| Start date | Jan 1, 2004 |
| First posted | Apr 19, 2006 |
| Last update posted | Jun 8, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: